Novavax Reports Second Quarter 2009 Financial Results

... in five auction rate securities with a par value of $8.1 million and a fair value of $6.0 million. In addition to the other than ... income related to the recovery of fair value for four of the securities. The net ...

NxStage Reports Second Quarter 2009 Financial Results

... the benefit of a $2.1 million change in fair value of financial instruments. Cash and cash ... Adjusted EBITDA numbers, beliefs regarding the value of strategic business relationships and ... (1,081) (4,372) (1,891) Change in fair value of financial instruments - ...

Endo Pharmaceuticals Reports Strong Second Quarter 2009 Financial Results

... primarily attributable to the changes in the value of contingent consideration associated with the ... any estimates for future changes in the fair value of contingent consideration, which could have a ... purchase accounting, of the change in the future value of contingent consideration associated with the ...

4th BTLtec Conference on 24-25 Sep in Graz, Austria features Biomass to Liquids Innovators Sharing Updates on Pyrolysis and Gasification Technologies, Syngas Application, BTL Value Chain and a Site Visit to the Biomass CHP Gussing Plant.

... syngas application and the complete BTL value chain. The final highlight to the event will be a ... stakeholders involved in the Biomass to Liquids value chain from all over the world. The conference ... with cost effective solutions for the entire BTL value chain, from Transporting Feedstock to Conversion ...

China-Biotics, Inc. Reports Fourth Quarter and Full Year Fiscal 2009 Financial Results

... a $1 million gain related to the change in fair value of convertible notes, non-GAAP net income ... a $3.1 million gain related to the change in fair value of convertible notes, non-GAAP net income ... of book gains related to the change in the fair value of the $25 million in convertible notes the ...

New Report Just Published: World Endoscopy Systems Market Report

... Market (2008E): Percentage Breakdown of value Sales for Olympus, Johnson & Johnson, ... Market (2007): Percentage Breakdown of value Sales for Karl Storz, Olympus, Smith & ... Market (2008E): Percentage Breakdown of value Sales for Olympus, Fujinon, and Pentax ...

Guy J. Quigley Resigns as Chairman and CEO of The Quigley Corporation: Quigley Leaves Company He Founded 20 Years Ago

... the QR-333 compound has potential to generate value for stockholders. Conversations with four ... and demonstrate another source of potential value for stockholders Guy J. Quigley, Chairman, ... several compounds which have reached a point of value inflection." "The new Board is now tasked ...

ClearTrial Industry Expert to Lead Session at DIA Annual Meeting on Improving Accrual and Contract Management in Clinical Trials

... biopharma executives will discuss how Earned value Management can improve control over clinical ... Accrual and Contract Management with Earned value Management" at the DIA 45th Annual Meeting. ... is becoming even more critical. Earned value Management (EVM), a widely accepted practice in ...

CardioDynamics Agrees to be Acquired by SonoSite for $1.35 Per Share

... price on June 8, 2009. The aggregate transaction value will be approximately $12.3 million, including ... We are pleased with SonoSite's recognition of the value that we have produced in creating a new medical ... toward our long-stated goal of adding clinical value and reducing healthcare system costs in ...

HUYA Bioscience Announces Strategic Collaboration With the Shenyang Pharmaceutical University

... and biopharma companies looking to maximize the value of their pre-clinical and clinical stage drugs ... to enhance development efficiency and value creation in world-wide markets for China-sourced ... for building and maximizing the worldwide value of biopharmaceutical innovation in China. HUYA is ...

Keryx Biopharmaceuticals Announces Appointment of Ron Bentsur as Chief Executive Officer

... make him ideally-suited to unlock the inherent value of our late-stage pipeline." Mr. Bentsur ... at an exercise price equal to the fair market value of the stock as of May 20, 2009, the date of ... new chief executive officer to build shareholder value through a better appreciation by the market of ...

Simcere Pharmaceutical Group Reports Unaudited First Quarter 2009 Results

... exchange ratio was determined based on the fair value of replacement restricted shares so that the fair value of the replacement restricted shares to be issued ... would be approximately equivalent to the fair value of the share options surrendered by an ....

Cell Therapeutics Amends 'Modified Dutch Auction' Tender Offer for up to $89.2 million of Its Outstanding Convertible Notes

... to exchange shares of its common stock, no par value (the "Common Stock"), and cash for an aggregate ... exchange shares of Common Stock and cash with a value not greater than $600 nor less than $550 (the ... validly tendered and not withdrawn, with such value determined by a "Modified Dutch Auction" ...

China Biologic Products Announces Strong First Quarter 2009 Results

... with the acquisition of Dalin as result of fair value adjustments as well as additional professional ... recognized of a loss in the change in fair value of derivative liability in the amount of $0.4 ... -40,247 -- Change in fair value of warrant liabilities ...

ThromboGenics NV: Business Update

... will continue to generate significant shareholder value throughout the remainder of 2009 as we continue to maximize the value of our exciting product pipeline." ... that LSRP is in a better position to create value from PlGF, given its current development status. ...

Cell Therapeutics to Exchange up to $89.2 million of Its Outstanding Convertible Notes in a 'Modified Dutch Auction' Tender Offer

... to exchange shares of its common stock, no par value ("Common Stock"), and cash for an aggregate of ... Notes, holders will receive consideration with a value not greater than $300 nor less than $250 (the "Exchange Consideration"), with such value determined by a "Modified Dutch Auction" ...

ViroPharma Incorporated Reports First Quarter 2009 Financial Results

... as the goodwill write off arising from our book value being lower than our market capitalization at ... Cinryze inventory which was recorded at fair value in purchase accounting. This fair value of inventory will increase cost of sales until ...

Beckman Coulter Announces First Quarter 2009 Results

... statement of earnings. c) Fair market value inventory adjustment - During the first quarter ... million charge related to the fair value of acquired inventory sold in the first ... costs (a) 26.4 0.7 Fair market value inventory adjustment (c) - ...

Failing to Demonstrate Value of Innovation is Top Risk Facing Life Sciences Sector, According to Ernst & Young

... on Life Sciences companies to demonstrate value for the products they develop, according to The ... are likely to increase demands to demonstrate value in the years ahead, as they confront mounting ... ability to innovate and create shareholder value for years to come." The top 10 risks facing ...

Hovione Opens its New API Plant in Cork

... into variable costs, reduces risk, provides added value and assured results. By being the manufacturing ... with a high volume low cost strategy value proposition; the former is the ideal plant for a ... synthesis business model is an unbeatable value proposition. This allows the pharma innovator ...

Vasogen Announces First Quarter 2009 Results

... include the potential to realize value from the monetization of certain intangible ... 342 13,862 Change in fair value of embedded derivatives - ... (487) Accretion in carrying value of senior convertible notes payable ...

Cell Therapeutics Satisfies NASDAQ Listing Requirements to Continue to Trade on NASDAQ Capital Market

... compliance with the minimum $35 million market value of listed securities requirement for a minimum of ... "We look forward to adding greater shareholder value through our submission of a New Drug Application ... its non-compliance with the $50 million market value of listed securities requirement for continued ...

ThermoGenesis Announces Abstracts to Be Presented at Upcoming Stem Cell Therapy Conference

... opportunity for the industry to be aware of the value of our devices in the collection and storage of ... Davis , School of Veterinary Medicine explore the value of equine umbilical cord blood as a source of ... and how certain biomaterials may enhance the value of equine stem cells and the implications of ...

New Clinical Study Shows Masimo PVI(TM) Accurately Predicts Fluid Responsiveness in the ICU

... Belgium, is the first to show the potential value of Masimo PVI to predict fluid responsiveness ... step, researchers found that a "threshold PVI value of 20 identified patients with PPV >15% with a ... In the second step, researchers found that a PVI value of 20 was an effective threshold for ...

IDM Pharma Reports 2008 Financial Results

... areas we believe can provide the most near term value to our stockholders and to ensure we have ... periods were to record the change in the fair value of warrants issued in February and June 2007. ... exchange gain, which results from changes in the value of the dollar versus the Euro on the dollar ...

New Discoveries on a Fingertip Test for Screening Silent Heart Disease Promising Results of Recent Clinical Studies to be Presented during the 2009 American College of Cardiology Conference, March 29th - April 1st in Orlando

... five clinical studies evaluating the predictive value of VENDYS®, the new FDA-approved ... five clinical studies evaluating the predictive value of VENDYS®, the new FDA-approved ... that I am aware of with such a high predictive value for detection of high risk coronary patients. We ...

Bavarian Nordic Publishes its Annual Results 2008

... and has laid a strong foundation for further value creation in 2009 and the years ahead. The ... subscription of up to 25,000 shares of a nominal value of DKK 10 at an exercise price of DKK 124 ... the abovementioned award of warrants. The value of each warrant equals DKK 39 and is calculated ...

Empirical Search Strategies Seeks Downside Protection Option at Avigen, Inc.

... measure described by the Biotechnology value Fund ("BVF"). ESS believes a clearly articulated ... continuity and understanding of how to maximize value from the Genzyme partnership. It may seem ... management has taken to maximize shareholder value and ...

Champions Biotechnology Reports Fiscal 2009 Third Quarter Financial Results

... platforms and tumor specific data to enhance the value of oncology drugs, reports its financial results ... Pharmaceuticals to realize the potential upside value of Salirasib, Concordia's novel compound for the ... tumor specific data to enhance and accelerate the value of oncology drugs. The Company's Preclinical ...

Biotechnology Value Fund Urges Stockholders to Remove and Replace Current Board of Avigen, Inc. in an Effort to Protect and Maximize Stockholder Value

... NEW YORK, March 12 /PRNewswire/ -- Biotechnology value Fund, L.P. ("BVF"), today announced that it has ... to join its campaign to maximize stockholder value by voting the GOLD proxy card today. BIOTECHNOLOGY value FUND, L.P. VOTE THE ENCLOSED GOLD ...

ThromboGenics Announces Business Update and 2008 Full Year Results

... corporate milestone, the signing of a high value strategic alliance with Roche for its novel ... will be able to generate significant shareholder value as it continues to maximize the value of its exciting product pipeline. Business ...

Caliper Life Sciences Reports Fourth Quarter and Full Year 2008 Results

... imaging system, and the expectation that the value of task orders Caliper will receive under the EPA ... accounting revenue and cost of sales fair value adjustments due to business combination ... 2) We exclude purchase accounting revenue fair value adjustments (net of associated costs) ...

Micromet, Inc. To Regain Rights to Blinatumomab in North America; Reports Financial Results for the Fourth Quarter and Full Year ended December 31, 2008

... well positioned to move our programs to the next value step." Recent Developments relating to ... an increase during the year in the fair value of warrants that we issued in a 2007 private ... non-cash gain for this item in 2007. The fair value of the warrants is calculated based on the ...

Campbell Alliance Brand Management Practice to Present at EyeForPharma's Oncology Summit USA and Oncology Market Access Europe Conference

... building blocks for maximizing the commercial value of new oncology products. Specifically, the ... the essential elements of maximizing commercial value for oncology products, but will focus on ... and myriad other aspects of maximizing the value of pharmaceutical assets. The team has also ...

Cell Therapeutics Announces Receipt of NASDAQ Listing Update

... Capital Market, including the $35 million market value of listed securities requirement or one of its ... its non-compliance with the $50 million market value of listed securities requirement for continued ... by April 6, 2009, including the market value of listed securities requirement, as well as ...

BVF Acquisition LLC Extends Avigen Tender Offer to April 3, 2009

... (the "Purchaser"), an affiliate of Biotechnology value Fund L.P. ("BVF"), which has commenced a cash ... CONCERNING PARTICIPANTS Biotechnology value Fund, L.P. ("BVF"), together with the other ... by Avigen at the request of BVF and Biotechnology value Fund II, L.P. ("BVF2"). BVF STRONGLY ADVISES ...

Mindray Announces 2008 Fourth Quarter and Full Year Results

... compensation expense, acquired inventory fair value adjustments, acquired intangible assets ... compensation expense, acquired inventory fair value adjustments, acquired intangible assets ... compensation, acquired inventory fair value adjustments and expense and/or ...

Vasogen Announces 2008 Year-End Results

... include the potential to realize value from the monetization of certain intangible ... 188 787 Change in fair value of forward foreign exchange contracts ... (930) (1,279) Accretion in carrying value of senior convertible notes payable ...

Boston Scientific Resolves Outstanding Litigation Matter, Finalizes Goodwill Impairment Charge

... cash flow position, represent a reduction in value of intangible assets. The expense associated with this reduction in value is not included in Boston Scientific's non-GAAP ... the full economic effect of the reduction in value of those intangible assets. ...

BVF Acquisition LLC Extends Avigen Tender Offer to March 6, 2009

... (the "Purchaser"), an affiliate of Biotechnology value Fund L.P. ("BVF"), which has commenced a cash ... CONCERNING PARTICIPANTS Biotechnology value Fund, L.P. ("BVF"), together with the other ... by Avigen at the request of BVF and Biotechnology value Fund II, L.P. ("BVF2"). BVF STRONGLY ADVISES ...